CohBar, Inc. CohBar, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Science
    • Overview
    • Platform Technology
    • Pipeline
  • News & Media
    • Press Releases
    • Publications
    • Events
    • Media
    • Newsroom
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers
  • Search

Press Releases

News & Media

News & Media

  • Press Releases
  • Publications
  • Events
  • Media
  • Newsroom

CohBar’s CEO to Participate on the New Breakthroughs in Aging Biology Panel at the BIO 2020 Digital Conference

May 27, 2020

CohBar Reports First Quarter 2020 Financial Results and Provides Business Update

May 14, 2020

CohBar’s Chief Operating Officer Jon Stern Plans to Step Down from Management Role

May 13, 2020

CohBar To Target COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with its Apelin Receptor Agonist Peptides

May 5, 2020

CohBar’s Abstract for the American Thoracic Society 2020 International Conference Published in the American Journal of Respiratory and Critical Care Medicine

May 1, 2020

CohBar to Announce 2020 First Quarter Financial Results and Provide Business Update on May 14, 2020

Apr 30, 2020

CohBar Announces Acceptance of Late Breaking Abstract on its Antifibrotic Peptides at The American Thoracic Society 2020 International Conference

Apr 14, 2020

CohBar Provides Update on CB4211 Phase 1b Study for NASH and Obesity

Mar 30, 2020

CohBar Reports Fourth Quarter 2019 Financial Results and Provides Business Update

Mar 12, 2020

CohBar to Hold Investor Meetings at the ROTH Virtual Conference

Mar 12, 2020
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...14
    © 2021 CohBar, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Sitemap